3 ms·
It's interesting that a single person dying in a gene therapy trial killed gene therapy as a field, but we're happily giving 1/3 of immunotherapy cancer treatme
by dekhn 10y ago
It's interesting that a single person dying in a gene therapy trial killed gene therapy as a field, but we're happily giving 1/3 of immunotherapy cancer treatment immune disorders. Kind of makes you wonder how that happened.